Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1966-1-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-1427
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13 Pt 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
473-84
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:5214325-Cortisone,
pubmed-meshheading:5214325-Dexamethasone,
pubmed-meshheading:5214325-Female,
pubmed-meshheading:5214325-Humans,
pubmed-meshheading:5214325-Male,
pubmed-meshheading:5214325-Multiple Sclerosis,
pubmed-meshheading:5214325-Prednisone,
pubmed-meshheading:5214325-Prognosis,
pubmed-meshheading:5214325-Statistics as Topic
|
pubmed:year |
1965
|
pubmed:articleTitle |
The long-term treatment of multiple sclerosis with corticoids.
|
pubmed:publicationType |
Journal Article
|